Mini-Mental State Examination score and B-type natriuretic peptide as predictors of cardiovascular and total mortality in an elderly general population

References

• Schupf N, Costa R, Luchsinger J, Tang MX, Lee JH, Mayeux R. Relationship between plasma lipids and all-cause mortality in nondemented elderly. J Am Geriatr Soc. 2005;53:219–26.
   PubMed Web of Science ®Google Scholar
• Oates DJ, Berlowitz DR, Glickman ME, Silliman RA, Borzecki AM. Blood pressure and survival in the oldest old. J Am Geriatr Soc. 2007;55:383–8.
   PubMed Web of Science ®Google Scholar
• Takata Y, Ansai T, Soh I, Akifusa S, Sonoki K, Fujisawa K, . Association between body mass index and mortality in an 80-year-old population. J Am Geriatr Soc. 2007;55:913–7.
   PubMed Web of Science ®Google Scholar
• Wang TJ, Larson MG, Levy D, Benjamin EJ, Leip EP, Omland T, . Plasma natriuretic peptide levels and the risk of cardiovascular events and death. N Engl J Med. 2004; 350:655–63.
   PubMed Web of Science ®Google Scholar
• Kistorp C, Raymond I, Pedersen F, Gustafsson F, Faber J, Hildebrandt P. N-terminal pro-brain natriuretic peptide, C-reactive protein, and urinary albumin levels as predictors of mortality and cardiovascular events in older adults. JAMA. 2005;293:1609–16.
   PubMed Web of Science ®Google Scholar
• Wallen T, Landahl S, Hedner T, Nakao K, Saito Y. Brain natriuretic peptide predicts mortality in the elderly. Heart. 1997;77:264–7.
   PubMed Web of Science ®Google Scholar
• Kelman HR, Thomas C, Kennedy GJ, Cheng J. Cognitive impairment and mortality in older community residents. Am J Public Health. 1994;84:1255–60.
   PubMed Web of Science ®Google Scholar
• Larson EB, Shadlen MF, Wang L, McCormick WC, Bowen JD, Teri L, . Survival after initial diagnosis of Alzheimer disease. Ann Intern Med. 2004;140:501–9.
   PubMed Web of Science ®Google Scholar
• Stump TE, Callahan CM, Hendrie HC. Cognitive impairment and mortality in older primary care patients. J Am Geriatr Soc. 2001;49:934–40.
   PubMed Web of Science ®Google Scholar
• Nguyen HT, Black SA, Ray LA, Espino DV, Markides KS. Cognitive impairment and mortality in older Mexican Americans. J Am Geriatr Soc. 2003;51:178–83.
   PubMed Web of Science ®Google Scholar
• Fried LP, Kronmal RA, Newman AB, Bild DE, Mittelmark MB, Polak JF, . Risk factors for 5-year mortality in older adults: the Cardiovascular Health Study. JAMA. 1998; 279:585–92.
   PubMed Web of Science ®Google Scholar
• Strandberg TE, Pitkala KH, Tilvis RS. Predictors of mortality in home-dwelling patients with cardiovascular disease aged 75 and older. J Am Geriatr Soc. 2009;57:279–84.
   Google Scholar
• Ganguli M, Dodge HH, Shen C, Pandav RS, DeKosky ST. Alzheimer disease and mortality: a 15-year epidemiological study. Arch Neurol. 2005;62:779–84.
   PubMedGoogle Scholar
• Jagger C, Andersen K, Breteler MM, Copeland JR, Helmer C, Baldereschi M, . Prognosis with dementia in Europe: A collaborative study of population-based cohorts. Neurologic Diseases in the Elderly Research Group. Neurology. 2000;54(11 Suppl 5):16–20.
   Web of Science ®Google Scholar
• Kloppenborg RP, van den Berg E, Kappelle LJ, Biessels GJ. Diabetes and other vascular risk factors for dementia: which factor matters most? A systematic review. Eur J Pharmacol. 2008;585:97–108.
   PubMed Web of Science ®Google Scholar
• Fitzpatrick AL, Kuller LH, Lopez OL, Diehr P, O'Meara ES, Longstreth WT Jr, . Midlife and late-life obesity and the risk of dementia: cardiovascular health study. Arch Neurol. 2009;66:336–42.
   PubMed Web of Science ®Google Scholar
• Cacciatore F, Abete P, Ferrara N, Calabrese C, Napoli C, Maggi S, . Congestive heart failure and cognitive impairment in an older population. Osservatorio Geriatrico Campano Study Group. J Am Geriatr Soc. 1998;46:1343–8.
   PubMed Web of Science ®Google Scholar
• Zuccalà G, Pedone C, Cesari M, Onder G, Pahor M, Marzetti E, . The effects of cognitive impairment on mortality among hospitalized patients with heart failure. Am J Med. 2003;115:97–103.
   PubMed Web of Science ®Google Scholar
• Feola M, Rosso GL, Peano M, Agostini M, Aspromonte N, Carena G, . Correlation between cognitive impairment and prognostic parameters in patients with congestive heart failure. Arch Med Res. 2007;38:234–9.
   PubMed Web of Science ®Google Scholar
• Kerola T, Nieminen T, Sulkava R, Hartikainen S, Vuolteenaho O, Kettunen R. B-type natriuretic peptide as a predictor of declining cognitive function and dementia—a cohort study of an elderly general population with a 5-year follow-up. Ann Med. 2010;42:207–15.
   PubMed Web of Science ®Google Scholar
• McKeith IG, Galasko D, Kosaka K, Perry EK, Dickson DW, Hansen LA, . Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop. Neurology. 1996;47:1113–24.
   PubMed Web of Science ®Google Scholar
• Zung WW. A self-rating depression scale. Arch Gen Psychiatry. 1965;12:63–70.
   PubMed Web of Science ®Google Scholar
• Ala-Kopsala M, Magga J, Peuhkurinen K, Leipälä J, Ruskoaho H, Leppäluoto J, . Molecular heterogeneity has a major impact on the measurement of circulating N-terminal fragments of A- and B-type natriuretic peptides. Clin Chem. 2004;50:1576–88.
   PubMed Web of Science ®Google Scholar
• Greenland S. Dose-response and trend analysis in epidemiology: alternatives to categorical analysis. Epidemiology. 1995;6:356–65.
   PubMed Web of Science ®Google Scholar
• Bassuk SS, Wypij D, Berkman LF. Cognitive impairment and mortality in community-dwelling elderly. Am J Epidemiol. 2000;151:677–88.
   Google Scholar
• Iadecola C, Davisson RL. Hypertension and cerebrovascular dysfunction. Cell Metab. 2008;7:476–84.
   PubMed Web of Science ®Google Scholar
• Buerger K, Ernst A, Ewers M, Uspenskaya O, Omerovic M, Morgenthaler NG, . Blood-based microcirculation markers in Alzheimer's disease—diagnostic value of midregional pro-atrial natriuretic peptide/C-terminal endothelin-1 precursor fragment ratio. Biol Psychiatry. 2009;65: 979–84.
   PubMed Web of Science ®Google Scholar
• Vuolteenaho O, Ala-Kopsala M, Ruskoaho H. BNP as a biomarker in heart disease. Adv Clin Chem. 2005;40:1–36.
   PubMed Web of Science ®Google Scholar
• Redfield MM, Jacobsen SJ, Burnett JC Jr, Mahoney DW, Bailey KR, Rodeheffer RJ. Burden of systolic and diastolic ventricular dysfunction in the community: appreciating the scope of the heart failure epidemic. JAMA. 2003;289: 194–202.
   PubMed Web of Science ®Google Scholar
• Strandberg TE, Tilvis RS. C-reactive protein, cardiovascular risk factors, and mortality in a prospective study in the elderly. Arterioscler Thromb Vasc Biol. 2000;20: 1057–60.
   PubMed Web of Science ®Google Scholar
• Suwa M, Ito T. Correlation between cognitive impairment and left ventricular diastolic dysfunction in patients with cardiovascular diseases. Int J Cardiol. 2009;136:351–4.
   Google Scholar
• Allender S, Peto V, Scarborough P, Rayner M. Coronary heart disease statistics. British Heart Foundation; London 2008.
   Google Scholar
• Pyörälä K, Salonen JT, Valkonen T. Trends in coronary heart disease mortality and morbidity and related factors in Finland. Cardiology. 1985;72:35–51.
   PubMed Web of Science ®Google Scholar